Ildiko Csiki, MD, PhD
Advisor
Dr Csiki is an oncologist with over 20 years of experience in patient care and cancer research. She currently serves as the founder of the Wondrlink Foundation, a 501(c)(3) non-profit organization advancing awareness and access to life-saving therapies for patients with life-threatening illnesses. She is a board member of several for-profit and non-profit cancer organizations as well as a strategic advisor to biopharma. Previously, she spent 3 years at City of Hope as the Chief Commercial R&D Officer and prior to that she served as the Chief Medical Officer at Sensei Bio and completed an executive management program at the Wharton Business School focused on healthcare innovation and entrepreneurship. Prior to Sensei Bio, she held progressively senior roles in industry including Clinical Development Lead for pembrolizumab in GI malignancies at Merck. Dr. Csiki received her M.D. in Medicine and Ph.D. in Cancer Biology from Vanderbilt University. After residency and a subsequent Holman Pathway Research Fellowship also at Vanderbilt, she began her academic faculty career at the University of Pennsylvania as an Assistant Professor in the Perelman Cancer Center where she had an active clinical practice and a translational science laboratory focused on thoracic malignancies.
